Skip to main content

Research outputs

What type of research output do you want to show?

2026

Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC

Mulholland, K. E., Bourguet, M., Cheng, N., Rahman, O., Ezerina, D., Daly, L. A., . . . Sharpe, H. J. (2026). Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC. SCIENCE SIGNALING, 19(921). doi:10.1126/scisignal.ady9437

DOI
10.1126/scisignal.ady9437
Journal article

2025

Pervanadate-induced oxidation relieves autoinhibition of SRC protein tyrosine kinase

DOI
10.1101/2025.04.27.650842
Preprint

Redox regulation and dynamic control of brain-selective kinases BRSK1/2 in the AMPK family through cysteine-based mechanisms

DOI
10.7554/eLife.92536
Preprint

2024

PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup>sensor proteins

DOI
10.1101/2024.10.20.619163
Preprint

2023

Custom Workflow for the Confident Identification of Sulfotyrosine-Containing Peptides and Their Discrimination from Phosphopeptides

Daly, L. A., Byrne, D. P., Perkins, S., Brownridge, P. J., Mcdonnell, E., Jones, A. R., . . . Eyers, C. E. (2023). Custom Workflow for the Confident Identification of Sulfotyrosine-Containing Peptides and Their Discrimination from Phosphopeptides. JOURNAL OF PROTEOME RESEARCH, 22(12), 3754-3772. doi:10.1021/acs.jproteome.3c00425

DOI
10.1021/acs.jproteome.3c00425
Journal article

Mechanistic and evolutionary insights into isoform-specific 'supercharging' in DCLK family kinases.

DOI
10.1101/2023.03.29.534689
Preprint

TRIB2 as a potential target in AML resistant to target therapy

Marensi, V., Daly, L., Till, J. K., MacEwan, J. D., Eyers, E. C., & Eyers, A. P. (2023). TRIB2 as a potential target in AML resistant to target therapy. In BRITISH JOURNAL OF PHARMACOLOGY Vol. 180 (pp. 1270). Retrieved from https://www.webofscience.com/

Conference Paper

2022

2021

Displacement of PKA catalytic subunit from AKAP signaling islands drives pathology in Cushing’s syndrome

DOI
10.1101/2021.10.18.464848
Preprint

2020